We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. You will see that each toolkit has a small QR code icon in the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.
You may need to actively update to the latest release - RDS app version 4.7.1 - to see this improvement.
Updating to this latest version of the RDS app is also strongly recommended to get the full benefits of the new resilience arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits. To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Please get in touch with ann.wales3@nhs.scot with any questions.
NICE clinical guideline CG184 provides information on the investigation and management of gastro-oesophageal reflux disease (GORD) and dyspepsia in adults.
In most patients with GORD, adequate symptom control is the principal aim of treatment. Symptoms should be controlled by using the lowest dose of the most cost–effective agent (antacid, H2 receptor antagonist or proton pump inhibitor). An ‘on demand’ regimen is acceptable providing it is effective.
To indicate the category of a formulary medicine, updated sections adopt the following key:
Preferred list (P): First-line formulary choices.
Total list (T): Alternative choices when preferred list options not effective/not tolerated, or not indicated.
Specialist initiation (S1): Specialist initiation, or on the advice of a Consultant or Specialist Practitioner in this therapeutic area. Continuation in primary care is acceptable.
Specialist use only (S2): Supply via hospital, Homecare Service or a hospital based prescription (HBP) for dispensing by community pharmacy. Not prescribed in primary care setting.
NHSL Medicines Guidance